Tingting Liu

机构：Hubei University of Science and Technology · ORCID：0000-0001-9623-7114

发表论文 79 篇 · 总被引 696 次 · h-index 15

代表论文

• Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysis (2025 · EClinicalMedicine · 被引 21)
• Piezo1 regulates actin cytoskeleton remodeling to drive EMT in cervical cancer through the RhoA/ROCK1/PIP2 signaling pathway (2025 · Discover Oncology · 被引 10)
• The increased matrix stiffness caused by LOXL2 activates Piezo1 channels to promote the migration and invasion of cervical cancer cells (2025 · Discover Oncology · 被引 10)
• Establishment and Comparison of Detection Methods for Ricin and Abrin Based on Their Depurination Activities (2025 · Toxins · 被引 8)
• Machine learning-driven multi-targeted drug discovery in colon cancer using biomarker signatures (2025 · npj Precision Oncology · 被引 6)
• High expression of ADAR mediated by OGT promotes chemoresistance in colorectal cancer through the A-to-I editing pathway (2024 · Molecular Genetics and Genomics · 被引 6)